Ad blocking detected

Thank you for visiting CanadianInsider.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). Private browsing Firefox users should be able to disable tracking protection while visiting our website. Visit Mozilla support for more information. If you do not believe you have any ad-blocking software on your browser, you may want to try another browser, computer or internet service provider. Alternatively, you may consider the following if you want an ad-free experience.

Canadian Insider Ultra Club
$500/ year*
Daily Morning INK newsletter
+3 months archive
Canadian Market INK weekly newsletter
+3 months archive
30 publication downloads per month from the PDF store
Top 20 Gold, Top 30 Energy, Top 40 Stock downloads from the PDF store
All benefits of basic registration
No 3rd party display ads
JOIN THE CLUB

* Price is subject to applicable taxes.

Paid subscriptions and memberships are auto-renewing unless cancelled (easily done via the Account Settings Membership Status page after logging in). Once cancelled, a subscription or membership will terminate at the end of the current term.

IM Cannabis Corp. (C:IMCC)

Business Focus: N/A

INK Edge Outlook

Insider Chart - Past 6 Months

INK Ultra Money Free

Insider Filings

Latest 10 SEDI filings for IMCC within the last 6 months
Loading...
See all filings within the past 6 months

Company News

Oct 20, 2021 09:45 ET
IMC Announces Third Installment of Shares in Connection with the Panaxia Transaction
TORONTO, ON and GLIL YAM, ISRAEL / ACCESSWIRE / October 20, 2021 / IM Cannabis Corp. (the "Company" or "IM Cannabis") (CSE:IMCC, NASDAQ:IMCC), a leading medical and adult-use recreational cannabis company with operations in Israel, Germany and Canada, today announced the third installment of shares in connection with the previously announced acquisition of the Panaxia-to-the-Home online pharmacy and trading center with an IMC-GDP license from Panaxia Pharmaceutical Industries Israel Ltd. and Panaxia Logistics Ltd., p
Read full article
Sep 13, 2021 08:43 ET
Cannabis Industry Investor Presentations Now Available for On-Demand Viewing
Individual and institutional investors as well as advisors are invited to log-on to VirtualInvestorConferences.com to view the presentations
Read full article
See more news stories

Valuation Ratios

Industry
Sector
Beta
N/A
--
--
Price to Sales - TTM
8.92
6.64
13.00
Price to Book - most recent quarter
1.62
1.78
3.14
Price to Cash Flow per share - TTM
--
17.38
13.35
Price to Free Cash Flow per share - TTM
--
--
32.73
See all valuations

Short Report

DateNumber of Shares ShortedNet Change
Oct 15, 202151,025-75,822
Sep 30, 2021126,84784,383
Sep 15, 202142,464-210
See Short Report

Business Summary

Sector:  Healthcare Industry:  Pharmaceuticals

IM Cannabis Corp., formerly Navasota Resources Inc., is a Canada-based medical cannabis company. The company is focused on offering a full spectrum of government-licensed cannabis products, from generic to good manufacturing practice (GMP) certified and pharmaceutical-grade, for both wholesale and retail clients. The Company operates in the Israeli medical cannabis market by providing intellectual property and services to licensed producers. The Company has three wholly-owned subsidiaries: IMC, incorporated, IMC Portugal and IM Cannabis Canada Inc. The Company also has four partially-owned subsidiaries Adjupharm GmbH, IMC Ventures Ltd., Societe Amig Navasota Mining International S.A.R.L., and Africa Bauxite Corporation.

See business summary

 

Twitter

Search (past week) for $IMCC.CA

  • No tweets found